CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.2600
0.00 (0.00%)
Aug 14, 2025, 3:59 PM EDT
CytoDyn Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
| Revenue | - | - | - | 0.27 | - | Upgrade
|
| Cost of Revenue | - | - | 20.63 | 73.54 | 5.03 | Upgrade
|
| Gross Profit | - | - | -20.63 | -73.28 | -5.03 | Upgrade
|
| Selling, General & Admin | 7.26 | 10.82 | 17.14 | 44.3 | 34.32 | Upgrade
|
| Research & Development | -16.92 | 7.24 | 2.63 | 27.04 | 53.4 | Upgrade
|
| Operating Expenses | -9.66 | 18.06 | 19.94 | 72.13 | 89.52 | Upgrade
|
| Operating Income | 9.66 | -18.06 | -40.58 | -145.4 | -94.55 | Upgrade
|
| Interest Expense | -4.86 | -8.89 | -15.51 | -24.18 | -22.11 | Upgrade
|
| Interest & Investment Income | 0.57 | 0.22 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.85 | -3.06 | -18.43 | - | - | Upgrade
|
| EBT Excluding Unusual Items | 4.52 | -29.79 | -74.51 | -169.59 | -116.66 | Upgrade
|
| Asset Writedown | - | - | - | - | -10.05 | Upgrade
|
| Legal Settlements | - | - | - | -3.85 | -10.63 | Upgrade
|
| Other Unusual Items | -0.77 | -20.05 | -5.31 | -37.38 | -39.13 | Upgrade
|
| Pretax Income | 3.75 | -49.84 | -79.82 | -210.82 | -176.47 | Upgrade
|
| Net Income | 3.75 | -49.84 | -79.82 | -210.82 | -176.47 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.48 | 1.48 | 6.91 | 1.63 | 1.69 | Upgrade
|
| Net Income to Common | 2.26 | -51.32 | -86.74 | -212.45 | -178.15 | Upgrade
|
| Shares Outstanding (Basic) | 1,206 | 970 | 837 | 677 | 588 | Upgrade
|
| Shares Outstanding (Diluted) | 1,243 | 970 | 837 | 677 | 588 | Upgrade
|
| Shares Change (YoY) | 28.20% | 15.90% | 23.58% | 15.20% | 39.54% | Upgrade
|
| EPS (Basic) | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.05 | -0.10 | -0.31 | -0.30 | Upgrade
|
| Free Cash Flow | -8.77 | -10.98 | -25.11 | -77.72 | -117.7 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.12 | -0.20 | Upgrade
|
| Operating Margin | - | - | - | -54663.16% | - | Upgrade
|
| Profit Margin | - | - | - | -79867.67% | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -29219.17% | - | Upgrade
|
| EBITDA | 9.68 | -18.03 | -40.4 | -144.62 | -92.75 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.03 | 0.18 | 0.78 | 1.8 | Upgrade
|
| EBIT | 9.66 | -18.06 | -40.58 | -145.4 | -94.55 | Upgrade
|
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.